Eun-Ji Koh

Title: Eun-Ji Koh: Innovator in Pharmaceutical Composition

Introduction

Eun-Ji Koh is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of hyperlipidemia and hypertriglyceridemia. With a total of 2 patents to her name, her work is paving the way for innovative solutions in healthcare.

Latest Patents

Eun-Ji Koh's latest patents include a pharmaceutical composition for preventing or treating hyperlipidemia. This composition comprises (4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one or its pharmaceutically acceptable salt, along with an angiotensin II receptor blocker as active ingredients. Another notable patent is a method for treating hypertriglyceridemia, which includes the same compound in combination with amlodipine or its pharmaceutically acceptable salt at a synergistic ratio of about 4:1.

Career Highlights

Eun-Ji Koh is currently employed at Daewoong Pharmaceutical Co., Ltd., where she continues to innovate and develop new pharmaceutical solutions. Her work has garnered attention in the industry, contributing to advancements in the treatment of lipid-related conditions.

Collaborations

Eun-Ji Koh collaborates with esteemed colleagues, including Jong-Wook Lee and Sang-Ho Lee. Their combined expertise enhances the research and development efforts at Daewoong Pharmaceutical Co., Ltd.

Conclusion

Eun-Ji Koh is a trailblazer in the pharmaceutical industry, with her innovative patents addressing critical health issues. Her contributions are vital in the ongoing fight against hyperlipidemia and related diseases.